Key result
AGTR1 rs2638360 G allele linked to ~4.9-fold higher risk of hypertension.
Why the study?
Genetic variation in the renin-angiotensin system influences hypertension susceptibility, prompting evaluation of AGTR1 rs5186 and rs2638360 polymorphisms alongside pro-inflammatory cytokines IL-6 and IL-17 in an Iraqi population.
Case-Control (n=96)
No
In an Iraqi case-control cohort, AGTR1 polymorphisms rs2638360 and rs5186 and elevated serum IL-6 and IL-17 levels were significantly associated with hypertension susceptibility, though neither SNP correlated with disease severity or cytokine concentrations.
Answers are grounded in this paper and cite their sources.
AGTR1 variants and cytokine elevations may aid risk stratification in similar cohorts; leaves open clinical utility pending larger prospective validation.
Hypertension is a major and largely asymptomatic contributor to cardiovascular morbidity, and genetic variation within the renin–angiotensin system is an important determinant of individual susceptibility. This case–control study examined the physiological contribution of two single-nucleotide polymorphisms (SNPs) in the angiotensin II type 1 receptor gene (AGTR1), rs5186 and rs2638360, to hypertension, together with the serum concentrations of the pro-inflammatory cytokines interleukin-6 (IL-6) and interleukin-17 (IL-17), in a cohort from Al-Qadisiyah Province, Iraq. Forty-eight hypertensive patients—stratified into mild, moderate, and severe subgroups—and 48 apparently healthy controls were genotyped by tetra-primer amplification refractory mutation system PCR (tetra-ARMS-PCR), and ELISA quantified serum cytokines. For rs5186, the A allele was associated with increased risk (OR = 2.14, P < 0.01), the C allele and the AC genotype showed protective odds ratios (OR = 0.47 and 0.37, respectively; P < 0.05), and the AA genotype was associated with increased risk (OR = 11.50, P < 0.001). For rs2638360, the AA genotype and the A allele were protective (OR = 0.055 and 0.20, respectively; P < 0.0001), whereas the AG and GG genotypes and the G allele conferred increased risk (OR = 4.86, 6.05, and 4.89, respectively; P < 0.05). Neither SNP was significantly associated with hypertension severity. Control genotype frequencies conformed to Hardy–Weinberg equilibrium for rs2638360 but deviated significantly for rs5186 (P < 0.001), so the rs5186 results require confirmation by an independent genotyping method. IL-6 and IL-17 were markedly elevated in patients (6.01 ± 0.42 and 2.87 ± 0.25 pg/mL, respectively; P < 0.0001) but did not differ across genotypes. These findings suggest that AGTR1 rs5186 and rs2638360 are associated with hypertension susceptibility in the Iraqi population and are consistent with a contributory role of vascular inflammation in disease pathophysiology, offering potential targets for population-specific management strategies.
No takes yet. Share an insight, caveat, or question.
Hadeel Jabar Neama Almuoswi (2026) conducted a case-control in Hypertension (n=96). AGTR1 rs2638360 G allele vs. AGTR1 rs2638360 A allele was evaluated on Hypertension susceptibility (association of AGTR1 rs2638360 G allele with hypertension) (OR 4.8857, 95% CI 2.5850-9.2340, p=<0.0001). The AGTR1 rs2638360 G allele increased hypertension risk, while patients also showed elevated serum IL-6 and IL-17 levels.
Synapse has enriched 10 related papers. Consider them for comparative context: